Hans J. Hammers, MD of the University of Texas Southwestern Medical Center discusses Updated Results From a Phase I Study…
Krzysztof Krawczyk of the Department of Translational Medicine, Center for Molecular Pathology Lund University, Malmö, Sweden discusses the papillary renal…
Saeed Dabestani MD PhD student Lund University, Sweden discusses the Non-metastatic renal cell carcinoma follow-up, recurrences and outcomes a RECUR…
Axel Bex, MD, PhD, of The Netherlands Cancer Institute in Amsterdam discusses the Challenges in Surgical Trials for Kidney Cancer…
In this activity, meeting co-chair Dr. John P. Leonard provides the key take-home messages from the leukemia, myeloid disorders, and…
In this presentation from the 14th Annual Best of San Antonio – Breast Cancer: Bench to Bedside, Dr. Kathy S.…
In this presentation from the 14th Annual Best of San Antonio – Breast Cancer: Bench to Bedside, Dr. Debu Tripathy…
In this presentation from the 14th Annual Best of San Antonio – Breast Cancer: Bench to Bedside, Dr. Hope S.…
In this activity, meeting co-chair Dr. David P. Steensma provides the key take-home messages from the leukemia, myeloid disorders, and…
In this activity, meeting co-chair Dr. Robert Z. Orlowski provides the key take-home messages from the plasma cell disorder session…
Dr. Arnaud Mejean, MD presents the challenges in CARMENA from the 2017 12th Annual European Kidney Cancer Symposium, Munich Germany
Dr. Thomas Powles, MD presents the Challenges in Neoadjuvant Biomarker Trials at the 2017 12th Annual European Kidney Cancer Symposium,…
Axel Bex, MD presents Challenges In Surtime at the 2017 12th Annual European Kidney Cancer Symposium, Munich Germany   …
Dr. Cora Sternberg, MD presents the P.H.M. deMulder Lecture entitled From cytokines to targeted therapies to immunotherapy30 years of progress…
Bernard J. Escudier, MD introduces Dr. Cora Sternberg, MD before the P.J.M. dMulder Lecture at the 12th Annual European Kidney…
Martin Dreyling, MD of University of Munich Hospital in Grosshadern discusses the treatment trends for lymphoma in 2017, which include…
Martin Dreyling, MD of University of Munich Hospital in Grosshadern gives an overview of his presentation, CHRONOS-1, which shows the…
Martin Dreyling, MD of University of Munich Hospital in Grosshadern gives an update on immunotherapy, which was a hot topic…
Martin Dreyling, MD of University of Munich Hospital in Grosshadern explains the difference between copanlisib and other PI3K inhibitors, specifically…
Martin Dreyling, MD of University of Munich Hospital in Grosshadern discusses the impact of his clinical trial, CHRONOS-1, on current…
Michael Ciesielski, PhD of Roswell Park Cancer Institute discusses the treatment trends in 2017 for his field, neuro-oncology, which include…
Michael Ciesielski, PhD of Roswell Park Cancer Institute gives an overview of the AACR presentations, which show more data and…
Michael Ciesielski, PhD of Roswell Park Cancer Institute explains how intracellular targets are detected onto the cell surface. He states…
Michael Ciesielski, PhD of Roswell Park Cancer Institute explains how the clinical data will help better characterize which patients respond…
Michael Ciesielski, PhD of Roswell Park Cancer Institute discusses the impact his clinical trial has on clinicians and future research.…
Michael Ciesielski, PhD of Roswell Park Cancer Institute gives an overview of his abstract, Circulating CD9-GFAP-survivin exosomes during active specific…
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives her input on when patients should stop treatment. She…
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains how this clinical trial now allows clinicians and other…
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center discusses the treatment trends for 2017 in thoracic oncology. This…
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of her presentation which discussed a five-year…
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains the impact of her clinical trial on current clinicians…
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of some of the presentations that were…
Peter Albers, MD, from the Heinrich-Heine-University Düsseldorf, Germany, explains that there is a big debate on whether robots should be…
Thomas Powles, MBBS, MRCP, MD, from the Barts Cancer Institute, London, UK, discusses how checkpoint inhibitors can be used earlier…
Thomas Powles, MBBS, MRCP, MD, from the Barts Cancer Institute, London, UK, gives an overview of the use of checkpoint…
Susanne Osanto, MD, PhD, from the Leiden University Medical Center, Leiden, Netherlands, discusses the current landscape and future direction of…
Susanne Osanto, MD, PhD, from the Leiden University Medical Center, Leiden, Netherlands, discusses the clinical implications of circulating tumor cell…
Susanne Osanto, MD, PhD, from the Leiden University Medical Center, Leiden, Netherlands, discusses the clinical utility of circulating tumor cells…
Rong Na, MD, from the Huashan Hospital, Fudan University, Shanghai, China discusses germline mutations in prostate cancer at the European…
Peter Albers, MD, from the Heinrich-Heine-University Düsseldorf, Germany, discusses which factors are important to consider in surgical robots at the…
Jame Abraham, MD of Cleveland Clinic discusses his hopes for NSABP-FB10 becoming a Phase II and Phase III trial for…
Jame Abraham, MD of Cleveland Clinic gives an overview of his abstract, NSABP FB-10: Phase Ib dose-escalation trial evaluating trastuzumab…
Jame Abraham, MD of Cleveland Clinic discusses the key finding from his study shows the impact of neratinib for breast…
Jame Abraham, MD of Cleveland Clinic states that although breast cancer treatment has yet to include immunotherapy, it is still…
Jame Abraham, MD of Cleveland Clinic discusses the treatment trends for breast cancer, which include PARP inhibitors, CDK 4/6 Inhibitors,…
Mohamed Abazeed, MD, PhD of Cleveland Clinic explains the determinants of what allows tumor samples to be released into the…
Mohamed Abazeed, MD, PhD of Cleveland Clinic explains the need for a genomic encyclopedia for radiation oncology. He argues that…
Mohamed Abazeed, MD, PhD of Cleveland Clinic discusses his speciality, radiation oncology, and the treatment trends he sees for 2017.…
Mohamed Abazeed, MD, PhD of Cleveland Clinic discusses Joe Biden’s address to AACR and the importance of receiving funding from…
Mohamed Abazeed, MD, PhD of Cleveland Clinic discusses the impact of his panel discussion and his hopes towards the ability…
Mohamed Abazeed, MD, PhD of Cleveland Clinic gives an overview of his panel discussion, Radiation Science and Medicine Working Group…
In this roundtable discussion, Drs. Gerald Prager, Tanios Bekaii-Saab, and Eric Van Cutsem examine the safety and efficacy profiles of…
In this Key Insights activity, Dr. Scott Kopetz and conference chair David H. Ilson discuss the key non-colorectal cancer-related take-home…
In this Key Insights activity, Dr. Scott Kopetz and conference chair Axel Grothey discuss the key colorectal cancer-related take-home messages…
Recorded on site during the 18th European CongressL Perspectives in Lung Cancer, this activity features conference chairs Giorgio V. Scagliotti,…
Mark Emberton, MD, FRCS Urol, from University College London Hospitals NHS Foundation Trust, London, UK discusses the value of MRI…
Axel Merseburger, from the Schleswig-Holstein University Hospital, Lübeck, Germany, discusses the joint meeting of the EAU and Japanese Urological Association…
Jochen Walz, MD, from the Paoli-Calmettes Institute, Marseille, France, discusses the limitations of magnetic resonance imaging (MRI) in prostate cancer…
Joaquim Bellmunt, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the implications of earlier immune-oncology treatments for multidisciplinary…
Axel Merseburger, from the Schleswig-Holstein University Hospital, Lübeck, Germany, discusses the currently available androgen deprivation therapies (ADT) at the European…
Christian Stief, MD, from Ludwig-Maximilians-University, Munich, Germany discusses results from the ProtecT trial in prostate cancer at the European Association…
Axel Merseburger, from the Schleswig-Holstein University Hospital, Lübeck, Germany, speaks about highlights from the session on advanced prostate cancer at…
Maurizio Brausi, MD, from the AUSL Modena, B. Ramazzini Hospital, Modena, Italy, discusses clinical trials of robotic surgery in radical…
Mark Emberton, MD, FRCS Urol, from University College London Hospitals NHS Foundation Trust, London, UK discusses the value of videos…
Jochen Walz, MD, from the Paoli-Calmettes Institute, Marseille, France, discusses the advantages of using imaging information for prostate cancer diagnosis…
Joaquim Bellmunt, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, gives an overview of checkpoint inhibitors for urothelial carcinoma…
In this presentation from Lymphoma & Myeloma 2016, Dr. Kelly M. Trevino discusses strategies to focus on quality of life…
In this presentation from Lymphoma & Myeloma 2016, Dr. Jeremy S. Abramson argues for the use of novel agents for…
In this presentation from Lymphoma & Myeloma 2016, Dr. David G. Maloney argues for stem cell transplant for a 60…
In this presentation from Lymphoma & Myeloma 2016, Dr. Jeremy S. Abramson discusses the latest novel agents for the treatment…
In this presentation from Lymphoma & Myeloma 2016, Jia Ruan discusses the most promising new approaches and agents for the…
In this presentation from Lymphoma & Myeloma 2016, Dr. Kieron Dunleavy discusses the latest developments in the upfront and relapsed…
In this presentation from Lymphoma & Myeloma 2016, Dr. Sonali M. Smith discusses whether or not one should utilize cell…
In this presentation from Lymphoma & Myeloma 2016, Dr. George P. Canellos discusses the past, present, and future of Hodgkin…
How should we approach the adolescent/young adult Hodgkin lymphoma patient? Click to Earn CME Credit: http://bit.ly/2mFKBrY © 2016 Imedex, LLC.
Christian Stief, MD, from Ludwig-Maximilians-University, Munich, Germany discusses developments in prostate cancer presented at a video session at the European…
Axel Merseburger, from the Schleswig-Holstein University Hospital, Lübeck, Germany, discusses the use of social media in uro-oncology at the European…
Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor…
From our MPN Ask the Expert series, Patient Power viewer, Maryse, asks a question about the MPL mutation and if…
Joaquim Bellmunt, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, summarizes the aims and results of the KEYNOTE-045 (NCT02256436)…
Lee S. Schwartzberg, MD of University of Tennessee Health Science Center explains which patients should get endocrine therapy and genomic…
Lee S. Schwartzberg, MD of University of Tennessee Health Science Center explains the use of genomic profiling for prognoses in…
Lee S. Schwartzberg, MD of University of Tennessee Health Science Center discusses the treatment trends in 2017 for estrogen receptor…
Lee S. Schwartzberg, MD of University of Tennessee Health Science Center discusses current clinical trials and genomic profiling in breast…
Shaji K. Kumar, MD of Mayo Clinic
Shaji K. Kumar, MD of Mayo Clinic gives an overview of the upcoming treatment trends for multiple myeloma, which include…
Shaji K. Kumar, MD of Mayo Clinic discusses how to gain a better understanding in treating multiple myeloma. He states…
Shaji K. Kumar, MD of Mayo Clinic CHANGE TITLE–Myeloma
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School explains whether or not somatostatin analogues were needed to…
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School gives an overview of his discussion, Novel Treatment Options…
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School discusses the results of the NETTER-1 study, which concluded…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? explains what to do with patients who have neo-adjuvant chemotherapy and…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? stresses the importance of tailoring treatment options to patients’ specific risks.…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? discusses the role for regional nodal irradiation in breast cancer treatment.…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? gives an overview of the new radiation guidelines for treating patients…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? explains how to select effective radiation options for breast cancer treatment.…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? gives an overview of her presentation, “Evolving Radiation Therapy Recommendations for…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? discusses treatment trends in 2017 for breast cancer treatment. She states…
Clifford Goodman, PhD of Lewin Group gives an overview of the types of evidence that the National Comprehensive Cancer Network…
Clifford Goodman, PhD of Lewin Group discusses concerns over patient affordability with cancer care. He argues that the separation between…
Clifford Goodman, PhD of Lewin Group gives an overview of another theme from his session, which was disparities in cancer…
Clifford Goodman, PhD of Lewin Group gives an overview of the National Comprehensive Cancer Network’s (NCCN) guidelines program and the…
Clifford Goodman, PhD of Lewin Group discusses themes of his session, which included concerns over cutbacks for the National Institute…
Clifford Goodman, PhD of Lewin Group discusses concerns about a rollback in coverage, losses in preventive services, and affordability in…
Stephen B. Edge, MD of Roswell Park Cancer Institute gives an overview of the new staging system by the American…
Stephen B. Edge, MD of Roswell Park Cancer Institute discusses questions he received from the audience, one being whether or…
Stephen B. Edge, MD of Roswell Park Cancer Institute gives an overview of his presentation “Implications of the New AJCC…
Stephen B. Edge, MD of Roswell Park Cancer Institute explains how health care disparities have become a critical issue and…
Stephen B. Edge, MD of Roswell Park Cancer Institute discusses the importance of personalized medicine, specifically genomic profiling in breast…
Stephen B. Edge, MD of Roswell Park Cancer Institute discusses the American Joint Committee on Cancer (AJCC) and its collaboration…
Lois Ramondetta, MD of MD Anderson Cancer Center gives an overview of her presentation, HPV Vaccine Champion Training for Gynecologic…
Lois Ramondetta, MD of MD Anderson Cancer Center discusses the importance of communicating the safety and efficacy of the HPV…
Lois Ramondetta, MD of MD Anderson Cancer Center gives an overview of an HPV-related abstract that was discussed at the…
Jennifer Young Pierce, MD of Medical University of South Carolina gives an overview of her presentation, HPV Vaccine Champion Training…
Jennifer Young Pierce, MD of Medical University of South Carolina gives an overview of the practical guidelines for gynecologic oncologists…
Jennifer Young Pierce, MD of Medical University of South Carolina discusses the importance of spreading HPV vaccine awareness, especially the…
Jennifer Young Pierce, MD of Medical University of South Carolina gives an overview of the treatment trends for the HPV…
Elizabeth Swisher, MD of University of Washington Medical Center discusses the treatment trends for ovarian cancer for 2017. She highlights…
Elizabeth Swisher, MD of University of Washington Medical Center explains why it is crucial to use both germline and tumor…
Elizabeth Swisher, MD of University of Washington Medical Center discusses development of more efficient clinical tests that will accurately predict…
Elizabeth Swisher, MD of University of Washington Medical Center gives an overview of a second presentation that discussed the ARIEL2…
Elizabeth Swisher, MD of University of Washington Medical Center discusses her hopes in the ARIEL2 Trial in helping to optimize…
Ruben A. Mesa, MD of Mayo Clinic discusses questions from the audience that were asked during his session on the…
Ruben A. Mesa, MD of Mayo Clinic gives an overview of the upcoming treatment trends for myeloproliferative neoplasms, which include…
Ruben A. Mesa, MD of Mayo Clinic gives an overview of interesting topics, such as health disparities and access to…
Ruben A. Mesa, MD of Mayo Clinic explains the importance of the NCCN and its development of new guidelines for…
Ruben A. Mesa, MD of Mayo Clinic gives an overview of the new guidelines that are set for leukemia. He…
Saketh Guntupalli, MD of University of Colorado School of Medicine gives an overview of the kinds of treatment trends for…
Saketh Guntupalli, MD of University of Colorado School of Medicine explains how patients were picked for his clinical study and…
Saketh Guntupalli, MD of University of Colorado School of Medicine discusses the importance of his study and how he hopes…
Saketh Guntupalli, MD of University of Colorado School of Medicine gives his take on how women can deal with their…
Saketh Guntupalli, MD of University of Colorado School of Medicine discusses interesting topics that were discussed at the 2017 Society…
Saketh Guntupalli, MD of University of Colorado School of Medicine discusses the data of his presentation, which was a randomized…
Thomas Powles, MBBS, MRCP, MD, from the Barts Cancer Institute, London, UK, gives an overview of the KEYNOTE-052 (NCT02335424) trial…
Peter Albers, MD, from the Heinrich-Heine-University Düsseldorf, Germany, discusses the concept of a semi-live surgical masterclass at the European Association…
Maurizio Brausi, MD, from the AUSL Modena, B. Ramazzini Hospital, Modena, Italy, discusses the use of robotic surgery for urological…
Jochen Walz, MD, from the Paoli-Calmettes Institute, Marseille, France, discusses the use of magnetic resonance imaging (MRI) in targeting prostate…
Joaquim Bellmunt, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, discusses recent advances in treating genitourinary malignancies at the…
From our MPN Ask the Expert series, Patient Power viewer, Barb, asks a question about peripheral neuropathy as a side…
Susan C. Modesitt, MD of University of Virginia Health System gives an overview the hot topics and trends that were…
Susan C. Modesitt, MD of University of Virginia Health System discusses the treatment of sentinel lymph nodes, which unintentionally cause…
Susan C. Modesitt, MD of University of Virginia Health System explains whether or not hospital readmission is an appropriate marker…
Susan C. Modesitt, MD of University of Virginia Health System discusses the use of PARP inhibitors and their benefits towards…
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC discusses how the use of PARP Inhibitors work for Ovarian Cancer…
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC discusses the use of PARP Inhibitors and in combination with Anti-VEGF,…
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC explains why the use of molecular analysis to determine therapy choice…
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC discusses novel agents, Olaparib and Rucaparib, that target BRCA mutations in…
Don Dizon, MD of Massachusetts General Hospital discusses data that argued how platinum sensitivity was an important predictor for Rucaparib…
Don Dizon, MD of Massachusetts General Hospital gives an overview of the treatment trends for 2017 in ovarian cancer treatment,…
Don Dizon, MD of Massachusetts General Hospital gives an overview of the SOLO2 Trial and the use of olaparib in…
Don Dizon, MD of Massachusetts General Hospital discusses the use of novel agents in ovarian cancer. He states that Olaparib…
Don Dizon, MD of Massachusetts General Hospital discusses the use of immunotherapy in cervical cancer treatment. He explains a clinical…
Learn more about personalized medicine, also known as precision medicine, in this web interview with Patient Power Host Andrew Schorr…
Christina Annunziata, MD, PhD of National Institutes of Health discusses how some novel agents may meet the guidelines for accelerated…
Christina Annunziata, MD, PhD of National Institutes of Health explains how the phase 2-3 design decreases the number of patients…
Christina Annunziata, MD, PhD of National Institutes of Health discusses how to take a drug from phase 1 to phase…
Christina Annunziata, MD, PhD of National Institutes of Health discusses how future research will be affected by clinical trials. She…
MPN experts, Dr. Michael Grunwald from Carolinas HealthCare System’s Levine Cancer Institute and Dr. Srdan Verstovsek from The University of…
Philip McCarthy, MD, Director of the Blood and Marrow Transplant Center at Roswell Park Cancer Institute in Buffalo, NY, shares…
Amrita Krishnan, MD FACP Director, Professor of Hematology/Hematopoietic Cell Transplantation gives an update to Multiple Myeloma Research at the MOASC…
Przemyslaw Twardowski, M.D., Clinical Professor of Medical Oncology, Director, Genitourinary Oncology, City of Hope Cancer Center and David Quinn, MBBS.,…
Sybil R. Green, JD, RPh, MHA talks about MACRA Rules are Final: Time to Implement the Quality Payment Program at…
James Suh, MD, Senior Pathologist and Associate Medical Director, Laboratory Director, Research Triangle Park, NC discusses the Comprehensive Genomic Profiling:…
At a recent MPN town meeting, Dr. Jigar Trivedi, Clinical Pharmacist Coordinator, Department of Pharmacy at Carolinas HealthCare System’s Levine…
David Spetzler, PhD, President and Chief Scientific Officer, Caris Life Sciences discusses Caris Molecular Intelligence® Evidence-Guided Molecular Analysis Services at…
Karen Reckamp, MD, Medical Director, Clinical Research, City of Hope Comprehensive Cancer Center discusses The Role of Utilizing Next Generation…
Edward B. Garon, MD, MS, Director of Thoracic Oncology, David Geffen School of Medicine at UCLA discusses Personalizing lung cancer…
In this presentation from Lymphoma & Myeloma 2016, Dr. Robert W. Chen argues in favor of the use of allogeneic…
In this presentation from Lymphoma & Myeloma 2016, Dr. Alison Moskowitz argues in favor of the use of serial novel…
In this presentation from Lymphoma & Myeloma 2016, Dr. Koen van Besien argues for stem cell transplant-based therapy in the…
In this presentation from Lymphoma & Myeloma 2016, Dr. Ann S. LaCasce argues for radion therapy in the treatment of…
In this presentation from Lymphoma & Myeloma 2016, Dr. Leandro Cerchietti discusses novel therapeutic strategies for B cell lymphomas. Click…
In this presentation from Lymphoma & Myeloma 2016, Dr. David Weinstock discusses new targets in peripheral T cell lymphomas. Click…
In this presentation from Lymphoma & Myeloma 2016, Dr. Steven Treon discusses new insights into the biology and treatment of…
In this presentation from Lymphoma & Myeloma 2016, Dr. Swaminathan P. Iyer discusses novel agents in the pipleine for the…
In this presentation from Lymphoma & Myeloma 2016, Dr. John N. Allan provides an update on Richter’s syndrome. Click to…
In this presentation from Lymphoma & Myeloma 2016, Dr. Neil E. Kay discusses optimal approaches for the management of chronic…
Stephen J. Russell, MD, PhD of Mayo Clinic discusses how viral therapy results will trigger a race to complete clinical…
Stephen J. Russell, MD, PhD of Mayo Clinic explains why viral therapy may prove to be a transformational addition to…
Stephen J. Russell, MD, PhD of Mayo Clinic explains why recombinant measles and recombinant vesicular stomatitis virus are ideal adjunct…
Elizabeth A. Repasky, PhD of Roswell Park Cancer Institute discusses how stress reducing beta blockers combined with immunotherapy may increase…
Elizabeth A. Repasky, PhD of Roswell Park Cancer Institute explains how patients on beta blockers may do better with immunotherapy…
Elizabeth A. Repasky, PhD of Roswell Park Cancer Institute gives an overview of her presentation that was presented at ASCO-SITC…
Graham P. Pawelec, PhD of Universitätsklinikum Tübingen explains how new data suggests immunosenescence may not be a factor in immunotherapy…
Heather McArthur, MD of Cedars-Sinai Medical Center discusses the importance of combination strategies in treatment for negative breast cancer. Specifically,…
Heather McArthur, MD of Cedars-Sinai Medical Center discusses the most interesting research she has seen at the ASCO-SITC Symposium. This…
Heather McArthur, MD of Cedars-Sinai Medical Center gives an overview of a poster discussion that was presented at the ASCO-SITC…
Heather McArthur, MD of Cedars-Sinai Medical Center discusses a Phase 1 Study that was being presented at ASCO-SITC. This study…
Heather McArthur, MD of Cedars-Sinai Medical Center discusses the importance of checkpoint blockade in breast cancer. With the biomarker PDL-1,…
James L. Gulley, MD, PhD of National Cancer Institute at the National Institutes of Health discusses promising approaches for looking…
James L. Gulley, MD, PhD of National Cancer Institute at the National Institutes of Health discusses the new research regarding…
James L. Gulley, MD, PhD of National Cancer Institute at the National Institutes of Health gives an overview of the…
Claire Friedman, MD of Memorial-Sloan Kettering talks about the different types of combinations in immunotherapy. She suggests that two combined…
Claire Friedman, MD of Memorial-Sloan Kettering advises healthcare professionals to use Nivolumab and Ipilimumab in treating patients with advanced melanoma,…
Claire Friedman, MD of Memorial-Sloan Kettering discusses the importance of novel combinations for immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium…
Claire Friedman, MD of Memorial-Sloan Kettering discusses the use of combination therapy for patients with melanoma at the ASCO-SITC Clinical…
Lawrence Fong, MD of University of California, San Francisco discusses the use of more combinations therapies, like Nivolumab and Ipilimumab.…
Lawrence Fong, MD of University of California, San Francisco explains how there are several combination therapies to study, but not…
Lawrence Fong, MD of University of California, San Francisco discusses upcoming combination therapies for melanoma treatment that will be FDA…
Ezra E.W. Cohen, MD of University of California, San Diego explains how immunotherapy is expanding for cancer treatment into new…
Ezra E.W. Cohen, MD of University of California, San Diego states that in 2017, we will see more combination immuno-therapy…
Ezra E.W. Cohen, MD of University of California, San Diego explains how biomarkers and combination therapy may be the path…
Ezra E.W. Cohen, MD of University of California, San Diego gives an overview of presentations that were discussed at ASCO-SITC.…
Stephen M. Ansell, MD, PhD of Mayo Clinic discusses the abstracts and new data that were presented at the second…
Stephen M. Ansell, MD, PhD of Mayo Clinic discusses the promising and exciting new results from CAR T-Cell data for…
Keith Argenbright, MD of UT Southwestern Medical Center discusses the geographical barriers for cancer survivorship. In these undeserved areas, which…
Keith Argenbright, MD of UT Southwestern Medical Center discusses his presentation “Driving Survivorship Home,” which was presented at ASCO’s 2017…
Keith Argenbright, MD of UT Southwestern Medical Center explains how he finds patients for his Mobile Survivorship program. He states…
Keith Argenbright, MD of UT Southwestern Medical Center discusses the advantages of a mobile survivorship program. He states that there…
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University discusses the research he found most intriguing…
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University discusses how radiation has changed for invasive…
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University discusses which patients with low-risk prostate cancer…
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University explains the difference between the side effects…
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University diseases how the use of radiation has…
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University gives an overview of his presentation “Best…
Nicholas J. Vogelzang, MD, FAnnual Meeting, FACP of Comprehensive Cancer Centers of Nevada explains his perspective on how to integrate…
Nicholas J. Vogelzang, MD, FAnnual Meeting, FACP of Comprehensive Cancer Centers of Nevada explains how treatment for prostate cancer has…
Nicholas J. Vogelzang, MD, FAnnual Meeting, FACP of Comprehensive Cancer Centers of Nevada explains how and when immunotherapy will be…
Nicholas J. Vogelzang, MD, FAnnual Meeting, FACP of Comprehensive Cancer Centers of Nevada discusses how the clinical trials, CHAARTED and…
Nicholas J. Vogelzang, MD, FAnnual Meeting, FACP of Comprehensive Cancer Centers of Nevada discusses when and where does chemotherapy fit…
Nicholas J. Vogelzang, MD, FAnnual Meeting, FACP of Comprehensive Cancer Centers of Nevada explains why he believes that all metastatic…
Nicholas J. Vogelzang, MD, FAnnual Meeting, FACP of Comprehensive Cancer Centers of Nevada explains why BRCA 1 and BRCA 2…
Ulka N. Vaishampayan, MD of Karmanos Cancer Institute explains what the biggest challenges are in facing patients and providers in…
Ulka N. Vaishampayan, MD of Karmanos Cancer Institute discusses how immunotherapies are being integrated renal cell carcinoma treatment. She states…
Ulka N. Vaishampayan, MD of Karmanos Cancer Institute explains why chemotherapy has no role for patients with kidney cancer. She…
Ulka N. Vaishampayan, MD of Karmanos Cancer Institute discusses the research that she thought was most intriguing at Annual Meeting…
At Patient Power’s 2016 town meeting at Levine Cancer Institute in Charlotte, Dr. Srdan Verstovsek explains why MPNs cause night…
Neal D. Shore, MD, FACS of Carolina Urologic Research Center explains how emerging data on resistance has changed treatment for…
Neal D. Shore, MD, FACS of Carolina Urologic Research Center discusses how CHAARTED and STAMPEDE impacted his treatment for patients…
Neal D. Shore, MD, FACS of Carolina Urologic Research Center discusses how and where chemotherapy fits into treating patients with…
Neal D. Shore, MD, FACS of Carolina Urologic Research Center gives his take on which metastatic castration-resistant prostate cancer patients…
Neal D. Shore, MD, FACS of Carolina Urologic Research Center explains how BRCA1 and BRCA2 genetic testing are significantly changing…
Wendy S. Harpham, MD, FACP of Presbyterian Hospital of Dallas discusses the medical benefits of finding and nourishing hope, which…
Wendy S. Harpham, MD, FACP of Presbyterian Hospital of Dallas advises on how to focus on hope for the best…
Wendy S. Harpham, MD, FACP of Presbyterian Hospital of Dallas explains why there is no one or right approach to…
Mohamad E. Allaf, MD of Johns Hopkins University School of Medicine discusses potential approaches physicians should consider when treating metastatic…
Marcus Butler, MD, from the Princess Margaret Cancer Centre, Toronto, Canada, discusses data on the efficacy of pembrolizumab treatment in…
Patrick Miqueu, PhD, from the Jules Bordet Institute in Brussels, Belgium, describes a pilot project to improve the collaboration and…
Lydia Makaroff, PhD, from the European Cancer Patient Coalition, introduces the coalitions new position paper, The Value of Innovation in…
Scott Murray, MD, FRCGP, FRCP Edin from the University of Edinburgh, Edinburgh, Scotland, discusses the talk he gave on different…
Richard Neal, MB, ChB, PhD, FRCGP, from the Leeds Institute of Health Sciences, Leeds, UK, discusses his talk on reducing…
Katsuo Usuda, MD, PhD, from Kanazawa Medical University, Ishikawa, Japan argues that diffusion-weighted magnetic resonance imaging (DWI, MRI) will soon…
Mohamad E. Allaf, MD of Johns Hopkins University School of Medicine discusses how hopeful he is when it comes to…
Mohamad E. Allaf, MD of Johns Hopkins University School of Medicine discusses which non-metastatic renal cell cancer patients should receive…
Matthew I. Milowsky, MD of North Carolina at Chapel Hill School of Medicine discusses how genomics are changing the way…
Matthew I. Milowsky, MD of North Carolina at Chapel Hill School of Medicine discusses how genomics are helping us understand…
Matthew I. Milowsky, MD of University of North Carolina at Chapel Hill School of Medicine discusses his presentation, “Urothelial Carcinoma:…
Jeffrey M. Holzbeierlein, MD of University of Kansas Hospital gives his take on the most promising data coming out of…
Jeffrey M. Holzbeierlein, MD of University of Kansas Hospital discusses presentations he found interesting at the symposium, specifically David J.…